These findings reveal an important role of inhibition of immune cell trafficking, a crucial component of inflammatory responses [52], in this ‘intermediate’ phenotype of responders with CRP > 1 mg/L, who are in remission from depression but still have elevated CRP levels. This evidence concerns the gene CRP and major depressive disorder.